Table 3.
Demographic and laboratory results of the subclinical hypothyroid and the control group.
| Subclinical hypothyroid n = 50 |
Control n = 50 |
P | |
|---|---|---|---|
| Age (mean ± SD) |
36.80 ± 8.19 | 35.42 ± 7.64 | 0.31 |
|
| |||
| TSH (mIU/mL) | 7.25 [IQR: 5.94–8.61] |
1.88 [IQR: 1.46–2.50] |
<0.0001 |
|
| |||
| FT3 (ng/dL) | 2.99 ± 0.36 | 3.32 ± 0.43 | <0.0001 |
|
| |||
| FT4 (ng/dL) | 1.08 [IQR: 1.02–1.18] |
1.20 [IQR: 1.13–1.34] |
<0.0001 |
|
| |||
| Total-C (mg/dL) | 204.5 ± 40.9 | 176.4 ± 13.6 | <0.0001 |
|
| |||
| TG (mg/dL) | 115 [IQR: 82.7–133.2] |
81.50 [IQR: 69.7–110.75] |
0.001 |
|
| |||
| HDL-C (mg/dL) | 56.34 ± 12.06 | 54.68 ± 10.96 | 0.51 |
|
| |||
| LDL-C (mg/dL) | 134 [IQR: 110–143] |
108.5 [IQR: 97.75–117] |
<0.0001 |
|
| |||
| Lp(a) (mg/dL) | 17.55 [IQR: 12.8–53.5] |
17.45 [IQR: 10.95–22.02] |
0.07 |
|
| |||
| Excess Lp(a) percent N (%) | N: 21 (42%) | N: 6 (12%) | 0.001 |
|
| |||
| BMI (kg/m2) | 26.36 ± 2.22 | 24.9 ± 2.52 | 0.03 |
|
| |||
| HOMA | 1.68 ± 0.58 | 1.59 ± 0.62 | 0.43 |
Normally distributed values are indicated as mean ± SD; nonnormaly distributed values are indicated as median and interquartile ranges.
TSH: thyroid stimulating hormone, FT4: free thyroxin, Total-C: total cholesterol, TG: triglyceride, HDL: high density lipoprotein, LDL: low density lipoprotein, Lp(a): lipoprotein(a), and BMI: body mass index; HOMA for insulin resistance index.
P values are the differences of subclinical hypothyroid and the control group.